Clinical Trial Update: Treatment of Larotaxel/Docetaxel, +/- Trastuzumab, After Anthracycline-cyclophosphamide in Breast Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating larotaxel/docetaxel with or without trastuzumab in breast cancer patients after anthracycline-cyclophosphamide; the study status is com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Larotaxel (larotaxel)
• Trastuzumab (trastuzumab)

Snippet

Sponsor: Sanofi | Conditions: Breast Neoplasms | Phase 2 | Status: COMPLETED